Apellis Pharmaceuticals buy Global_Player
Start price
28.07.23
/
50%
€27.40
Target price
28.07.24
-
Performance (%)
-17.52%
End price
05.08.23
€22.60
Summary
This prediction ended on 05.08.23 with a price of €22.60. The price of Apellis Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.52%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% | 63.642% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% | 88.123% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% | 83.527% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% | 68.755% |
Comments by Global_Player for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Buy Apellis Pharmaceuticals
In the thread Trading Apellis Pharmaceuticals
Buy beendet
Stopped prediction by Global_Player for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€49.00
14.12.23
14.12.23
-
14.12.24
14.12.24
10.20%
23.12.23
23.12.23


